MRP Under Process
Official PMBI MRP is being updated for catalog code 2191.
Locate Jan Aushadhi KendraClinical Overview
Progesterone (Injection IP 100mg/2ml) is a bioidentical progestogen on the WHO Model List of Essential Medicines. Identical to human ovarian luteal progesterone, it transforms the proliferative endometrium into a secretory endometrium, promotes blastocyst implantation, suppresses myometrial oxytocin receptor expression, and inhibits uterine contractions to maintain pregnancy. Indicated for luteal phase support in assisted reproduction (IVF/ICSI), threatened and recurrent miscarriage, prevention of preterm birth in women with short cervix, secondary amenorrhea, and endometrial protection during estrogen HRT.
Active Pharmaceutical Ingredients
Verified Clinical References
Usage Guidelines
For Deep Intramuscular (IM) injection ONLY: 50 mg to 100 mg deep IM daily or on alternate days as prescribed by the reproductive endocrinologist/obstetrician. Warm vial slightly between palms to decrease viscosity of oily vehicle; inject slowly using a deep 21G/22G needle. Continue through 10-12 weeks of gestation as directed.
General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.
Possible Side Effects
Common: Drowsiness/somnolence (oral route), dizziness, headache, breast tenderness, abdominal bloating, nausea, and vaginal discharge/leakage (vaginal route). Rare/Severe: Thromboembolic events (DVT, PE), cholestatic jaundice, depression, and severe allergic reactions.
*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.
Precautions & Warnings
Use caution when driving or operating machinery due to central sedative metabolites (allopregnanolone) when taken orally. Contraindicated in active venous thromboembolism, severe hepatic impairment, undiagnosed vaginal bleeding, porphyria, and missed abortion. Safe and indicated during early pregnancy under specialist care.
Schedule H (Prescription Required)
This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.
Medical Disclaimer: Statutory Gynecological, Obstetric & Endocrinological Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice or reproductive healthcare guidance. Hormonal medications, uterotonics, corticosteroids, fertility therapies, and emergency contraceptives have profound systemic actions and must be administered strictly under the supervision of a registered gynecologist, obstetrician, or endocrinologist.